Evidence map›Paper›PMID 28935548›Full record

ReviewWorld neurosurgery2017

Chronic Subdural Hematoma: A Historical and Clinical Perspective.

Ronald Sahyouni, Khodayar Goshtasbi, Amin Mahmoodi, Diem K Tran, Jefferson W Chen

4 registry-linked trialsAbstract readHistorical ArticleReview
In one paragraph

Review in World neurosurgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 47 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04272996 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Endovascular Embolization for Chronic Subdural Hematomas Following Surgical Evacuation

TypeinterventionalSponsorAugusta UniversityRan2019 to 2024Enrolled60ConditionsChronic SDH and the Efficacy of EmbolizationArmsCraniotomy only, Craniotomy + Endovascular embolization of the middle meningeal vessels
NCT04511572 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Improving the Outcome of Chronic Subdural Hematoma by Embolization of Middle Meningeal Artery (ELIMINATE)

TypeinterventionalSponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Ran2020 to 2025Enrolled170ConditionsChronic Subdural HematomasArmsembolization of the middle meningeal artery
NCT05713630 phase3recruitingnot on this mapstarted 2026, after this paper: background citation

TRACE STUDY: A Randomized Controlled Trial Using Tranexamic Acid in the Treatment of Subdural Hematoma

TypeinterventionalSponsorUnity Health TorontoRan2026 to 2030Enrolled130ConditionsSubdural HematomaArmsTranexamic acid (TXA), Placebo
NCT06323434 recruitingnot on this mapstarted 2024, after this paper: background citation

Spinal CSF Leaks in Chronic Subdural Hematoma

TypeobservationalSponsorUniversity of FreiburgRan2024 to 2026Enrolled220ConditionsChronic Subdural Hematoma
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Observational
  7. Review
  8. Observational
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ronald SahyouniUC Irvine School of Medicine, Irvine, California, USA; UC Irvine Department of Biomedical Engineering, Irvine, California, USA.
Khodayar GoshtasbiUC Irvine School of Medicine, Irvine, California, USA.
Amin MahmoodiUC Irvine Department of Neurological Surgery, Irvine, California, USA.
Diem K TranUC Irvine Department of Neurological Surgery, Irvine, California, USA.
Jefferson W ChenUC Irvine Department of Neurological Surgery, Irvine, California, USA. Electronic address: jeffewc1@uci.edu.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008620 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI GOLDIN, ALAN L · 1999 to 2023
$8.1M
NIGMS NIH HHS T32 GM008620
6 · The paper itself

Abstract

backgroundThis review aims to highlight the clinical complexity of chronic subdural hematoma (cSDH) while presenting a brief historical discussion of cSDH.

methodsA thorough literature search of published English-language papers was performed in PubMed, Ovid, and Cochrane databases.

resultscSDH affects 1-5.3 per 100,000 individuals annually, with the incidence expected to rise as the U.S. population ages. The symptoms of cSDH are often nonspecific, with headaches being the most common complaint. Other symptoms include weakness, balance and gait problems, and memory problems.

conclusionsA variety of clinical factors must be taken into account in the treatment of cSDH, and the multifaceted treatment paradigms continue to evolve.

Indexed as

CraniotomyDrainageTrephiningAftercareHematoma, Subdural, ChronicHistory, 17th CenturyHistory, 18th CenturyHistory, 19th CenturyHistory, 20th CenturyHumansNeurosurgical ProceduresUnited StatesChronicHematomaMembraneNeurosurgerySubduralTrauma

Identifiers

PMID28935548
PMCPMC12747318

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.